ARTHUR-D.-LITTLE
6.3.2023 13:02:36 CET | Business Wire | Press release
Arthur D. Little (ADL) has published the fourth edition of its Autonomous Mobility Journal, which looks at the latest developments in autonomous vehicles (AVs) and the market for autonomous mobility going forward.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230306005447/en/
Arthur D. Little: Autonomous Mobility Journal, Fourth Edition (Graphic: Business Wire)
As well as highlighting current industry dynamics, the journal also includes:
- A special focus on robotaxis around the world
- An overview of the AV market in Hong Kong
- An interview with Prof. Omaimah Bamasag, Deputy of Transport Enablement at the Transport General Authority of the Kingdom of Saudi Arabia
While the AV market remains in its infancy and, like other industries, has suffered setbacks due to the Covid-19 pandemic and semiconductor shortages, companies are still working hard to advance AV technologies to the point of mainstream acceptance and deployment. The buoyancy of the global electric vehicle (EV) market also provides a technology pathway for autonomous mobility features to be more readily adopted in the coming years.
An interesting aspect of the autonomous mobility landscape is the high number of start-ups in this space that have gone public through special-purpose acquisition companies (SPACs) rather than more conventional IPOs. Many of these companies have shown fragility and lack of resilience in a difficult market context – however, it is hoped that increased focus on EV innovation by major OEMs will create additional traction in the AV market, and boost the prospects of AV start-ups.
ADL believes that the outlook for robotaxis is more positive, with “city robotaxis” which can operate in any mapped area of a city, even in extreme weather conditions, likely by 2027. “Anywhere robotaxis”, which can operate on unmapped or unmade roads, could also be a reality by 2030.
ADL’s analysis of the AV market in Hong Kong reveals how it has positioned itself as a leader in the autonomous mobility ecosystem through the successful coordination of key elements, including strategy, regulations, stakeholder integration, infrastructure and technology. Finally, Prof. OmaimahBamasag outlines Saudi Arabia’s ambitious goals for AV transport, including major autonomy-based initiatives such as the Neom and Red Sea projects in the Kingdom’s economic zone.
Joseph Salem, Partner in ADL’s Travel & Transportation practice, comments: “While the development of autonomous mobility solutions globally remains experiential, industry players are clearly on the lookout for technological and business model innovation to unlock value-creating use cases. In this journal, we provide a realistic overview of recent developments and industry dynamics, including the key considerations and challenges that the AV market currently faces. We hope it provides food for thought and look forward to feedback from our readers.”
The journal is available for download here: https://tinyurl.com/24cr7dxj
For further information, please visit www.adlittle.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230306005447/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
